Page 1 | Search Results | Blood | American Society of Hematology

1-6 of 6

Sort by

Sort Order Select

Journal Articles

A Retrospective Cohort Study of Interferon-α Therapy in Myeloproliferative Neoplasms; Adverse Events, Thromboembolic Incidence and Causes of Termination of Therapy

Marie Lindgren, MD, Jan Samuelsson, MD PhD, Lars Nilsson, MD PhD, Håvar Knutsen, MD, Waleed Ghanima, MDPhD, Maria Åström, MD PhD, Elisabeth Ejerblad, MD, Anna Hugosson, MD, Peter L. Johansson, MD PhD, Björn Andréasson, MD PhD

Blood (2014) 124 (21): 1861.

https://doi.org/10.1182/blood.V124.21.1861.1861

Published: 2014

Journal Articles

Characterisation of the Stem and Progenitor Cell Hierarchy in Patients with CMML

Onima Chowdhury, MD PhD, Petter S Woll, PhD, Una Kjällquist, PhD, Helen Doolittle, MD, Rikard Erlandsson, PhD, Kristina Anderson, MD PhD, Ingunn Dybedal, MD PhD, Adam Mead, MDPhD, Sally-Ann Clark, PhD, Mette S. Holm, MD PhD, Peter Hokland, MD DMSc, Lars Nilsson, MD PhD, Sten Linnarsson, PhD, Eva Hellstrom-Lindberg, MD PhD, Sten Eirik W Jacobsen, MD PhD

Blood (2014) 124 (21): 1896.

https://doi.org/10.1182/blood.V124.21.1896.1896

Published: 2014

Journal Articles

Diverse Genetic Lesions In Myelodysplastic Syndromes Originate Exclusively In Rare MDS Stem Cells

Blood (2013) 122 (21): 4195.

https://doi.org/10.1182/blood.V122.21.4195.4195

Published: 2013

Journal Articles

Evaluation of Azacitidine in Transfusion-Dependent, Epo-Refractory Patients with Lower-Risk Myelodysplastic Syndrome,

Magnus Tobiasson, MD, Lena Brandefors, MD, Ingunn Dybedal, MD, PhD, Hege Garelius, MD, Michael Grövdal, MD, PhD, Inge Hoegh Dufva, MD, PhD, Lars Kjeldsen, MD, PhD, Lars Nilsson, MD, PhD, Astrid Olsnes Kittang, MD, PhD, Anna Porwit, MD, PhD, Leonie Saft, MD, Mette Skov Holm, MD, PhD, Lars Möllgård, MD, Phd, Eva Hellström-Lindberg

Blood (2011) 118 (21): 3798.

https://doi.org/10.1182/blood.V118.21.3798.3798

Published: 2011

Journal Articles

A Distinct Molecular Signature of Purified Cancer Stem Cells: Evidence for a Hematopoietic Stem Cell Origin of the 5q- Syndrome.

Lars Nilsson, MD, PhD, Patrik Edén, PhD, Eleonor Olsson, Robert Månsson, Ingbritt Åstrand-Grundström, Bodil Strömbeck, Ramin Tehranchi, MD, PhD, Kim Theilgaard-Mönch, Robert Hast, MD, PhD, Eva Hellström-Lindberg, MD, PhD, Jan Samuelsson, MD, PhD, Gösta Bergh, MD, PhD, Bertil Johansson, MD, PhD, Mikael Sigvardsson, PhD, Åke Borg, PhD, Sten-Eirik W. Jacobsen, MD, PhD

Blood (2005) 106 (11): 4382.

https://doi.org/10.1182/blood.V106.11.4382.4382

Published: 2005

Journal Articles

Erythropoiesis Is Highly Stimulated in CD34 + Cells in Low-Risk Myelodysplastic Syndromes (MDS) with an Improper Mitochondrial Function.

Ramin Tehranchi, MD, Rosangela Invernizzi, MD, PhD, Boris Zhivotovsky, PhD, Bengt Fadeel, MD, PhD, Ann-Mari Forsblom, Erica Travaglino, Jan Samuelsson, MD, Robert Hast, MD, PhD, Lars Nilsson, MD, PhD, Rolf Wibom, PhD, Alf Grandien, PhD, Mario Cazzola, MD, PhD, Eva Hellstrom-Lindberg, MD, PhD

Blood (2004) 104 (11): 473.

https://doi.org/10.1182/blood.V104.11.473.473

Published: 2004

NARROW

A Retrospective Cohort Study of Interferon-α Therapy in Myeloproliferative Neoplasms; Adverse Events, Thromboembolic Incidence and Causes of Termination of Therapy

Characterisation of the Stem and Progenitor Cell Hierarchy in Patients with CMML

Diverse Genetic Lesions In Myelodysplastic Syndromes Originate Exclusively In Rare MDS Stem Cells

Evaluation of Azacitidine in Transfusion-Dependent, Epo-Refractory Patients with Lower-Risk Myelodysplastic Syndrome,

A Distinct Molecular Signature of Purified Cancer Stem Cells: Evidence for a Hematopoietic Stem Cell Origin of the 5q- Syndrome.

Erythropoiesis Is Highly Stimulated in CD34 + Cells in Low-Risk Myelodysplastic Syndromes (MDS) with an Improper Mitochondrial Function.

Email alerts

ASH Publications

American Society of Hematology

A Retrospective Cohort Study of Interferon-α Therapy in Myeloproliferative Neoplasms; Adverse Events, Thromboembolic Incidence and Causes of Termination of Therapy

Characterisation of the Stem and Progenitor Cell Hierarchy in Patients with CMML

Diverse Genetic Lesions In Myelodysplastic Syndromes Originate Exclusively In Rare MDS Stem Cells

Evaluation of Azacitidine in Transfusion-Dependent, Epo-Refractory Patients with Lower-Risk Myelodysplastic Syndrome,

A Distinct Molecular Signature of Purified Cancer Stem Cells: Evidence for a Hematopoietic Stem Cell Origin of the 5q- Syndrome.

Erythropoiesis Is Highly Stimulated in CD34 + Cells in Low-Risk Myelodysplastic Syndromes (MDS) with an Improper Mitochondrial Function.

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only